COVID-19
August 15, 2022
ROCHESTER, Minn. — Mayo Clinic researchers say the monoclonal antibody bebtelovimab, already authorized by the Food and Drug Administration for emergency use on the omicron[...]
November 3, 2020
November 3, 2020
October 30, 2020
October 29, 2020
October 28, 2020
October 28, 2020
Explore more topics
Sign up
Mayo Clinic Connect
An online patient support community